BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3139878)

  • 1. Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay.
    Haynes DR; Garrett IR; Whitehouse MW; Vernon-Roberts B
    J Rheumatol; 1988; 15(5):775-8. PubMed ID: 3139878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of T cell proliferation by gold sodium thiomalate and auranofin.
    Hashimoto K; Whitehurst CE; Lipsky PE
    J Rheumatol; 1994 Jun; 21(6):1020-6. PubMed ID: 7932408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antirheumatic gold salts on cytokine-induced neutrophil-dependent cytotoxicity for human endothelial cells.
    Bratt J; Palmblad J
    J Investig Med; 2000 Nov; 48(6):395-402. PubMed ID: 11094861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of auranofin: effects on humoral immune response.
    Walz DT; Dimartino MJ; Griswold DE
    J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.
    Walz DT; DiMartino MJ; Griswold DE
    J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auranofin, gold thiomalate, and gold thioglucose inhibit protein kinase C.
    Mahoney CW; Hensey CE; Azzi A
    Biochem Pharmacol; 1989 Oct; 38(19):3383-6. PubMed ID: 2510733
    [No Abstract]   [Full Text] [Related]  

  • 9. Unique properties of auranofin as a potential anti-rheumatic drug.
    Barrett ML; Lewis GP
    Agents Actions; 1986 Oct; 19(1-2):109-15. PubMed ID: 3099556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic inhibition of human B cell activation by gold sodium thiomalate and auranofin.
    Hirohata S; Nakanishi K; Yanagida T; Kawai M; Kikuchi H; Isshi K
    Clin Immunol; 1999 May; 91(2):226-33. PubMed ID: 10227815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of longterm treatment with auranofin and gold sodium thiomalate on immune function in the dog.
    Bloom JC; Thiem PA; Halper LK; Saunders LZ; Morgan DG
    J Rheumatol; 1988 Mar; 15(3):409-17. PubMed ID: 3132555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of auranofin and sodium aurothiomalate on interleukin-1 production from human monocytes in vitro.
    Remvig L; Enk C; Bligaard N
    Scand J Rheumatol; 1988; 17(4):255-62. PubMed ID: 3142038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro effect of gold complexes on bone resorption.
    Katz JM; Gray DH
    J Orthop Res; 1986; 4(2):188-93. PubMed ID: 3086527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chrysotherapy on cell mediated immune response.
    Lorber A; Jackson WH; Simon TM
    J Rheumatol Suppl; 1982; 8():37-45. PubMed ID: 6813490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent human leukocyte collagenase can be activated by gold thioglucose and gold sodium thiomalate, but not by auranofin.
    Sorsa T; Suomalainen K; Turto H; Lindy S
    Biosci Rep; 1987 Dec; 7(12):965-8. PubMed ID: 2840130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats.
    Garrett IR; Whitehouse MW; Vernon-Roberts B; Brooks PM
    J Rheumatol; 1985 Dec; 12(6):1079-82. PubMed ID: 3937896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.
    Griswold DE; Lee JC; Poste G; Hanna N
    J Rheumatol; 1985 Jun; 12(3):490-7. PubMed ID: 2931519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of TPA-induced NF-kappaB nuclear translocation and production of NO and PGE2 by the anti-rheumatic gold compounds.
    Yamashita M; Ashino S; Oshima Y; Kawamura S; Ohuchi K; Takayanagi M
    J Pharm Pharmacol; 2003 Feb; 55(2):245-51. PubMed ID: 12631417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of slow-acting antirheumatic drugs on blast formation of normal lymphocytes].
    Hamai T; Negishi M; Takahashi T
    Ryumachi; 1983 Aug; 23(4):193-201. PubMed ID: 6420896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.